Page last updated: 2024-12-05

4-fluorobiphenyl

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

4-Fluorobiphenyl is an organic compound with the formula C12H9F. It is a colorless solid that is used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals. The compound has been studied for its potential use as a building block in the development of novel drugs and other bioactive molecules. It is also of interest to researchers studying the mechanisms of environmental pollution and the bioaccumulation of organic compounds.'

Cross-References

ID SourceID
PubMed CID9461
CHEMBL ID122439
SCHEMBL ID412237
MeSH IDM0107386

Synonyms (36)

Synonym
AC-18713
1,1'-biphenyl, 4-fluoro-
para-fluorobiphenyl
nsc 56686
einecs 206-304-1
(4-fluorophenyl)benzene
4-fluoro-1,1'-biphenyl
nsc56686
324-74-3
biphenyl, 4-fluoro-
nsc-56686
4-fluorobiphenyl
p-fluorodiphenyl
inchi=1/c12h9f/c13-12-8-6-11(7-9-12)10-4-2-1-3-5-10/h1-9
4-fluorobiphenyl, 95%
1-fluoro-4-phenylbenzene
CHEMBL122439
4-fluoro-biphenyl
F0482
4-fluoro-1,1-biphenyl
p-fluorobiphenyl
AKOS006223689
FT-0618523
AB01065
SCHEMBL412237
4'-fluoro-biphenyl
4-flurobiphenyl
4'-fluorobiphenyl
4-fluoro-1,1'-biphenyl #
W-106839
4-fuorobiphenyl
4-fluoro-1,1'-diphenyl
DTXSID00186111
mfcd00011650
FS-4454
SY049810
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID89369Transthyretin (TTR) amyloidogenesis inhibition activity by employing an acid-mediated (pH 4.4) WTTTR amyloid fibril formation assay, at 7.2 uM conc.2004Journal of medicinal chemistry, Jan-15, Volume: 47, Issue:2
Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis.
AID1486518Inhibition of acid-induced wild type transthyretin (unknown origin) aggregation expressed in Escherichia coli pre-incubated for 30 mins before acid addition and further incubated for 72 hrs at 37 degC under dark conditions by UV-Vis spectrophotometry2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
AID1486519Binding affinity to transthyretin in human blood plasma assessed as plasma binding selectivity by measuring stoichiometry of small molecule bound to TTR incubated for 24 hrs at 37 degC by RP-HPLC2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (11.11)18.7374
1990's2 (22.22)18.2507
2000's4 (44.44)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.02

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.02 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.71 (4.65)
Search Engine Demand Index22.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.02)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (11.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]